非酒精性脂肪性肝病中肝纤维化状态与肝脏相关及心血管事件的风险差异
Risk Difference of Liver-Related and Cardiovascular Events by Liver Fibrosis Status in Nonalcoholic Fatty Liver Disease.
作者信息
Tamaki Nobuharu, Higuchi Mayu, Kurosaki Masayuki, Loomba Rohit, Izumi Namiki
机构信息
Department of Gastroenterology and Hepatology, Musashino Red Cross Hospital, Tokyo, Japan; NAFLD Research Center, Division of Gastroenterology and Hepatology, Department of Medicine, University of California San Diego, La Jolla, California.
Department of Gastroenterology and Hepatology, Musashino Red Cross Hospital, Tokyo, Japan.
出版信息
Clin Gastroenterol Hepatol. 2022 May;20(5):1171-1173.e2. doi: 10.1016/j.cgh.2021.07.021. Epub 2021 Jul 16.
Abstract
Nonalcoholic fatty liver disease (NAFLD) has affected more than one-fourth of the global population, thus emerging as a worldwide health and economic burden. The common causes of death in patients with NAFLD include cardiovascular disease (CVD), decompensation, and hepatocellular carcinoma (HCC). However, identifying the risk of these complications in patients with NAFLD remains an unmet need in clinical practice.
摘要
非酒精性脂肪性肝病（NAFLD）已影响全球超过四分之一的人口，因此成为一项全球性的健康和经济负担。NAFLD患者的常见死因包括心血管疾病（CVD）、失代偿和肝细胞癌（HCC）。然而，在临床实践中，识别NAFLD患者发生这些并发症的风险仍然是一项未得到满足的需求。
相似文献
1
Risk Difference of Liver-Related and Cardiovascular Events by Liver Fibrosis Status in Nonalcoholic Fatty Liver Disease.非酒精性脂肪性肝病中肝纤维化状态与肝脏相关及心血管事件的风险差异
Clin Gastroenterol Hepatol. 2022 May;20(5):1171-1173.e2. doi: 10.1016/j.cgh.2021.07.021. Epub 2021 Jul 16.
2
Fibrosis Severity as a Determinant of Cause-Specific Mortality in Patients With Advanced Nonalcoholic Fatty Liver Disease: A Multi-National Cohort Study.纤维化严重程度是晚期非酒精性脂肪性肝病患者死因特异性死亡率的决定因素：一项多国队列研究。
Gastroenterology. 2018 Aug;155(2):443-457.e17. doi: 10.1053/j.gastro.2018.04.034. Epub 2018 May 5.
3
AGA Clinical Practice Update on Screening and Surveillance for Hepatocellular Carcinoma in Patients With Nonalcoholic Fatty Liver Disease: Expert Review.AGA 临床实践更新：非酒精性脂肪性肝病患者肝细胞癌的筛查和监测：专家综述。
Gastroenterology. 2020 May;158(6):1822-1830. doi: 10.1053/j.gastro.2019.12.053. Epub 2020 Jan 30.
4
Hepatocellular and extrahepatic cancer risk in people with non-alcoholic fatty liver disease.非酒精性脂肪性肝病患者的肝细胞癌和肝外癌症风险。
Lancet Gastroenterol Hepatol. 2024 Feb;9(2):159-169. doi: 10.1016/S2468-1253(23)00275-3.
5
[Advances in diagnosis and treatment of nonalcoholic fatty liver disease].[非酒精性脂肪性肝病的诊断与治疗进展]
Zhonghua Gan Zang Bing Za Zhi. 2016 Feb;24(2):81-4. doi: 10.3760/cma.j.issn.1007-3418.2016.02.001.
6
Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: Implications for Liver Transplantation.非酒精性脂肪性肝病和非酒精性脂肪性肝炎的流行病学：对肝移植的影响。
Transplantation. 2019 Jan;103(1):22-27. doi: 10.1097/TP.0000000000002484.
7
Hepatocellular carcinoma in Japanese patients with nonalcoholic fatty liver disease and alcoholic liver disease: multicenter survey.日本非酒精性脂肪性肝病和酒精性肝病患者的肝细胞癌：多中心调查。
J Gastroenterol. 2016 Jun;51(6):586-96. doi: 10.1007/s00535-015-1129-1. Epub 2015 Oct 11.
8
Screening and interventions to prevent nonalcoholic fatty liver disease/nonalcoholic steatohepatitis-associated hepatocellular carcinoma.筛查和干预措施以预防非酒精性脂肪性肝病/非酒精性脂肪性肝炎相关肝细胞癌。
World J Gastroenterol. 2023 Jan 14;29(2):286-309. doi: 10.3748/wjg.v29.i2.286.
9
Hepatocellular carcinoma and non-alcoholic fatty liver disease.肝细胞癌与非酒精性脂肪性肝病。
Hepatol Int. 2019 Nov;13(6):688-694. doi: 10.1007/s12072-019-09995-8. Epub 2019 Nov 7.
10
Association of metabolic traits with occurrence of nonalcoholic fatty liver disease-related hepatocellular carcinoma: A systematic review and meta-analysis of longitudinal cohort studies.代谢特征与非酒精性脂肪性肝病相关肝细胞癌发生的关系：纵向队列研究的系统评价和荟萃分析。
Saudi J Gastroenterol. 2022 Mar-Apr;28(2):92-100. doi: 10.4103/sjg.sjg_260_21.
引用本文的文献
1
Predictors of Atherosclerotic Cardiovascular Disease Events in Patients with Metabolic Dysfunction-associated Steatotic Liver Disease.代谢功能障碍相关脂肪性肝病患者动脉粥样硬化性心血管疾病事件的预测因素
Intern Med. 2025 Jun 15;64(12):1791-1798. doi: 10.2169/internalmedicine.4373-24. Epub 2024 Nov 21.
2
Editorial: Cardiometabolic criteria matters in MASLD-Authors' reply.社论：代谢性心血管疾病标准在代谢相关脂肪性肝病中的重要性——作者回复
Aliment Pharmacol Ther. 2024 Oct;60(8):1128-1129. doi: 10.1111/apt.18243. Epub 2024 Sep 3.
3
Cardiometabolic criteria as predictors and treatment targets of liver-related events and cardiovascular events in metabolic dysfunction-associated steatotic liver disease.代谢相关脂肪性肝病中心血管代谢相关预测指标及治疗靶点与肝脏相关事件和心血管事件的关系。
Aliment Pharmacol Ther. 2024 Oct;60(8):1033-1041. doi: 10.1111/apt.18205. Epub 2024 Aug 8.
4
Enhanced Liver Fibrosis Score for Diagnosing Liver Fibrosis in Chronic Hepatitis.用于诊断慢性肝炎肝纤维化的增强肝纤维化评分
Diagnostics (Basel). 2024 Jun 21;14(13):1317. doi: 10.3390/diagnostics14131317.
5
Risk of Adverse Events in Anticoagulated Patients With Atrial Fibrillation and Nonalcoholic Fatty Liver Disease.患有心房颤动和非酒精性脂肪性肝病的抗凝患者发生不良事件的风险
J Clin Endocrinol Metab. 2024 Dec 18;110(1):208-217. doi: 10.1210/clinem/dgae394.
6
Monitoring disease progression in metabolic dysfunction-associated steatotic liver disease.监测代谢功能障碍相关脂肪性肝病的疾病进展
Aliment Pharmacol Ther. 2024 Jun;59 Suppl 1(Suppl 1):S41-S51. doi: 10.1111/apt.17752.
7
Detecting advanced liver fibrosis using ultrasound shear wave velocity measurement in the general population.在普通人群中使用超声剪切波速度测量来检测晚期肝纤维化。
Quant Imaging Med Surg. 2023 Oct 1;13(10):6493-6502. doi: 10.21037/qims-23-511. Epub 2023 Aug 28.
8
A Comparison of Alanine Aminotransferase Normalization between Pemafibrate and Bezafibrate in Patients with Nonalcoholic Fatty Liver Disease.非酒精性脂肪性肝病患者中苯扎贝特与非诺贝特的丙氨酸氨基转移酶正常化比较。
Intern Med. 2024 May 1;63(9):1185-1190. doi: 10.2169/internalmedicine.2248-23. Epub 2023 Sep 29.
9
Type 2 diabetes, hepatic decompensation, and hepatocellular carcinoma in patients with non-alcoholic fatty liver disease: an individual participant-level data meta-analysis.非酒精性脂肪性肝病患者的 2 型糖尿病、肝功能失代偿和肝细胞癌：个体参与者水平数据荟萃分析。
Lancet Gastroenterol Hepatol. 2023 Sep;8(9):829-836. doi: 10.1016/S2468-1253(23)00157-7. Epub 2023 Jul 4.
10
Risk of cardiovascular disease in lean patients with nonalcoholic fatty liver disease.非酒精性脂肪性肝病瘦型患者的心血管疾病风险。
BMC Gastroenterol. 2023 Jun 17;23(1):211. doi: 10.1186/s12876-023-02848-7.
本文引用的文献
1
Liver Stiffness by Magnetic Resonance Elastography Predicts Future Cirrhosis, Decompensation, and Death in NAFLD.磁共振弹性成像检测肝脏硬度可预测非酒精性脂肪性肝病患者的未来肝硬化、失代偿和死亡。
Clin Gastroenterol Hepatol. 2021 Sep;19(9):1915-1924.e6. doi: 10.1016/j.cgh.2020.09.044. Epub 2020 Sep 30.
2
Sex and gender: modifiers of health, disease, and medicine.性别与健康、疾病和医学。
Lancet. 2020 Aug 22;396(10250):565-582. doi: 10.1016/S0140-6736(20)31561-0.
3
Advanced fibrosis is associated with incident cardiovascular disease in patients with non-alcoholic fatty liver disease.晚期肝纤维化与非酒精性脂肪性肝病患者心血管疾病的发生有关。
Aliment Pharmacol Ther. 2020 Apr;51(7):728-736. doi: 10.1111/apt.15660. Epub 2020 Feb 11.
4
Cardiovascular risk factors in non-alcoholic fatty liver disease.非酒精性脂肪性肝病的心血管危险因素。
Liver Int. 2019 Jan;39(1):197-204. doi: 10.1111/liv.13973. Epub 2018 Oct 17.
5
Magnetic Resonance vs Transient Elastography Analysis of Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review and Pooled Analysis of Individual Participants.磁共振与瞬时弹性成像分析非酒精性脂肪性肝病患者：系统评价和个体参与者汇总分析。
Clin Gastroenterol Hepatol. 2019 Mar;17(4):630-637.e8. doi: 10.1016/j.cgh.2018.05.059. Epub 2018 Jun 14.
6
Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention.非酒精性脂肪性肝病和非酒精性脂肪性肝炎的全球负担：趋势、预测、危险因素和预防。
Nat Rev Gastroenterol Hepatol. 2018 Jan;15(1):11-20. doi: 10.1038/nrgastro.2017.109. Epub 2017 Sep 20.
7
Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases.非酒精性脂肪性肝病及其与心血管病和其他肝外疾病的关系。
Gut. 2017 Jun;66(6):1138-1153. doi: 10.1136/gutjnl-2017-313884. Epub 2017 Mar 17.
8
Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta-analysis.非酒精性脂肪性肝病中纤维化阶段导致的死亡风险增加：系统评价与荟萃分析
Hepatology. 2017 May;65(5):1557-1565. doi: 10.1002/hep.29085. Epub 2017 Mar 31.
9
Hepatic steatosis index: a simple screening tool reflecting nonalcoholic fatty liver disease.肝脂肪变性指数：一种反映非酒精性脂肪性肝病的简单筛查工具。
Dig Liver Dis. 2010 Jul;42(7):503-8. doi: 10.1016/j.dld.2009.08.002. Epub 2009 Sep 18.
Zotero 插件